{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:03:29Z","timestamp":1790424209968,"version":"4.1.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is caused by an autoantibody-mediated deficiency in ADAMTS13. In healthy individuals, ADAMTS13 has a folded conformation in which the central spacer (S) domain interacts with the C-terminal CUB domains. We recently showed that ADAMTS13 adopts an open conformation in iTTP and that patient immunoglobulin G antibodies (IgGs) can open ADAMTS13. Anti-ADAMTS13 autoantibodies in patients with iTTP are directed against the different ADAMTS13 domains, but almost all patients have autoantibodies binding to the cysteine\/spacer (CS) domains. In this study, we investigated whether the autoantibodies against the CS and CUB domains can disrupt the S-CUB interaction of folded ADAMTS13, thereby opening ADAMTS13. To this end, we purified anti-CS and anti-CUB autoantibodies from 13 patients with acute iTTP by affinity chromatography. The successfully purified anti-CS (10\/13 patients) and anti-CUB (4\/13 patients) autoantibody fractions were tested further in our ADAMTS13 conformation enzyme-linked immunosorbent assay to study whether they could open ADAMTS13. Interestingly, all purified anti-CS fractions (10\/10 patients) were able to open ADAMTS13. On the other hand, only half of the purified anti-CUB fractions (2\/4 patients) opened ADAMTS13. Our finding highlights that anti-CS autoantibodies that open ADAMTS13 are a common feature of the autoimmune response in iTTP.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004971","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T16:01:39Z","timestamp":1632499299000},"page":"4480-4484","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Anti-cysteine\/spacer antibodies that open ADAMTS13 are a common feature in iTTP"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-9229","authenticated-orcid":false,"given":"Laure","family":"De Waele","sequence":"first","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Curie","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"},{"name":"D\u00e9partement de M\u00e9decine Interne, CHU Charles Nicolles, Rouen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-6386","authenticated-orcid":false,"given":"Kadri","family":"Kangro","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"},{"name":"Icosagen Cell Factory O\u00dc, \u00d6ssu, Kambja, Tartumaa, Estonia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Tellier","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, INRAE, C2VN, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Kaplanski","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, INRAE, C2VN, Marseille, France;"},{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, CHU Conception, Aix-Marseille University, APHM, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"M\u00e4nnik","sequence":"additional","affiliation":[{"name":"Icosagen Cell Factory O\u00dc, \u00d6ssu, Kambja, Tartumaa, Estonia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-6349","authenticated-orcid":false,"given":"Claudia","family":"Tersteeg","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Biologique, H\u00f4pital Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris and EA3518, Institut de recherche Saint Louis, Universit\u00e9 de Paris, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Microangiopathies Thrombotiques, Service d\u2019H\u00e9matologie, H\u00f4pital Saint Antoine, Assistance Publique-H\u00f4pitaux de Paris and Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Biologique, H\u00f4pital Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris and EA3518, Institut de recherche Saint Louis, Universit\u00e9 de Paris, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"De Meyer","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-9070","authenticated-orcid":false,"given":"Elien","family":"Roose","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-8277","authenticated-orcid":false,"given":"Karen","family":"Vanhoorelbeke","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"issue":"22","key":"2021110816204699900_B1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med."},{"issue":"1","key":"2021110816204699900_B2","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"8","key":"2021110816204699900_B3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine."},{"issue":"2","key":"2021110816204699900_B4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/17474086.2016.1122515","article-title":"ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies","volume":"9","author":"Tersteeg","year":"2016","journal-title":"Expert Rev Hematol."},{"issue":"23","key":"2021110816204699900_B5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med."},{"issue":"44","key":"2021110816204699900_B6","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem."},{"issue":"9","key":"2021110816204699900_B7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica."},{"issue":"11","key":"2021110816204699900_B8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1538-7836.2006.02164.x","article-title":"Multiple B-cell clones producing antibodies directed to the spacer and disintegrin\/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura","volume":"4","author":"Luken","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2021110816204699900_B9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.thromres.2011.03.010","article-title":"Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Yamaguchi","year":"2011","journal-title":"Thromb Res."},{"issue":"5","key":"2021110816204699900_B10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/rth2.12379","article-title":"Generation and validation of small ADAMTS13 fragments for epitope mapping of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura [published correction appears in Res Pract Throm Haemost. 2021;5(3):456]","volume":"4","author":"Kangro","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"issue":"2","key":"2021110816204699900_B11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jth.15170","article-title":"Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura","volume":"19","author":"Vel\u00e1squez Pereira","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"52","key":"2021110816204699900_B12","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"issue":"52","key":"2021110816204699900_B13","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1073\/pnas.1413282112","article-title":"Allosteric activation of ADAMTS13 by von Willebrand factor","volume":"111","author":"Muia","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"issue":"11","key":"2021110816204699900_B14","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/jth.13149","article-title":"Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13","volume":"13","author":"Deforche","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2021110816204699900_B15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jth.13922","article-title":"An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura","volume":"16","author":"Roose","year":"2018","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2021110816204699900_B16","first-page":"353","article-title":"Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura","volume":"136","author":"Roose","year":"2020","journal-title":"Blood."},{"issue":"12","key":"2021110816204699900_B17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood."},{"issue":"6","key":"2021110816204699900_B18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/bloodadvances.2019001375","article-title":"Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function","volume":"4","author":"Schelpe","year":"2020","journal-title":"Blood Adv."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4480\/1833247\/advancesadv2021004971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4480\/1833247\/advancesadv2021004971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T16:21:37Z","timestamp":1636388497000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/21\/4480\/477029\/Anti-cysteine-spacer-antibodies-that-open-ADAMTS13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":18,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,11,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004971","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]}}}